On June 15, 2022, the U.S. Supreme Court released its decision regarding the cuts made by the Department of Health and Human Services (HHS) to the 340B Drug Pricing Program, finding that HHS acted outside its statutory authority in changing reimbursement rates for one group of hospitals without first surveying them on their costs. The 340B Drug Pricing Program allows hospitals and clinics that treat low-income, medically underserved patients to purchase certain “specified covered outpatient drugs” at discounted prices. (Read more...)

On June 17, 2022, the Centers for Medicare & Medicaid Services (CMS) published its proposed Home Health Prospective Payment System (HH PPS) for calendar year (CY) 2023. If CMS’s proposed rule is finalized as is, home health agencies (HHAs) will experience an $810 million pay cut from Medicare next year. Much of the decrease in home health payments proposed for 2023 is due to pay adjustments “to account for increased expenditures CMS contends resulted from a recently implemented payment system,” i.e., the Payment-Driven Groupings Model (PDGM). (Read more...)

A series of Federal Trade Commission (FTC) challenges to hospital mergers and acquisitions in 2022 indicates heightened regulatory scrutiny of hospital deals. Perhaps emboldened by the July 2021 executive order that focused attention on antitrust enforcement of hospital consolidation, the agency has voted to challenge a number of transactions, which has lead hospitals to call off the deals rather than challenge the government. This Health Capital Topics article reviews three of the largest transactions called off this year, two of which were announced in June. (Read more...) 

With home healthcare providers increasingly being viewed as a critical link in the array of patient-centered healthcare services aimed to bring care back into the community, technology will likely play a more prominent role in managing patient populations in need of home healthcare services. The final installment of this five-part series on the valuation of home health agencies (HHAs) will discuss the growing role of technology in home healthcare and the challenges of utilizing this technology post-COVID-19. (Read more...) 
"Study: Vertical Integration Not Financially Beneficial for Physicians" authored by HCC President, Todd A. Zigrang, MBA, MHA, FACHE, CVA, ASA, and, HCC Vice President and General Counsel, Jessica Bailey-Wheaton, Esq., was published by the St. Louis Metropolitan Medical Society in the April/May 2022 issue of St. Louis Metropolitan Medicine.

For more recently published material written by HCC, please visit www.healthcapital.com

On August 18, 2022, HCC President, Todd A. Zigrang, MBA, MHA, FACHE, CVA, ASA, and, HCC Senior Vice President and General Counsel, Jessica Bailey-Wheaton, Esq., will present on the topic of "Healthcare Regulatory Updates & Valuation Implications," during the National Association of Certified Valuators and Analysts (NACVA) 2022 Business Valuation and Financial Litigation Super Conference.